Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma

The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options

(2015) Emmanuel Gabriel et al.   Cancers

Burden of Disease Predicts Response to Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma

(2014) Diego J. Muilenburg et al.   ANNALS OF SURGICAL ONCOLOGY

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

(2014) Rebecca L. Read et al.   ANNALS OF SURGICAL ONCOLOGY

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities – Long-term follow-up of a randomised trial

(2014) Roger Olofsson Bagge et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion

(2014) Alessandro Testori et al.   JOURNAL OF SURGICAL ONCOLOGY

Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review

(2014) Hidde M. Kroon et al.   JOURNAL OF SURGICAL ONCOLOGY

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

(2014) Caroline Robert et al.   LANCET

Locoregional Therapies in Melanoma

(2014) Andrea M. Abbott et al.   SURGICAL CLINICS OF NORTH AMERICA

Resection of Residual Disease after Isolated Limb Infusion (ILI) Is Equivalent to a Complete Response after ILI-Alone in Advanced Extremity Melanoma

(2013) Joyce Wong et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma

(2013) Roger Olofsson et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

(2012) Axel Hauschild et al.   LANCET

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

(2012) Jeffrey A. Sosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Trends in Regional Therapy for Melanoma: Lessons Learned from 225 Regional Chemotherapy Treatments between 1995 and 2010 at a Single Institution

(2011) Amanda K. Raymond et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety

(2010) D. Moreno-Ramirez et al.   ONCOLOGIST

Safety and Efficacy of Isolated Limb Infusion With Cytotoxic Drugs in Elderly Patients With Advanced Locoregional Melanoma

(2009) Hidde M. Kroon et al.   ANNALS OF SURGERY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US

(2009) Georgia M. Beasley et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion

(2008) Georgia M. Beasley et al.   ANNALS OF SURGICAL ONCOLOGY

Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience

(2008) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER